BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33651718)

  • 21. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Koyuncu CF; Nag R; Lu C; Corredor G; Viswanathan VS; Sandulache VC; Fu P; Yang K; Pan Q; Zhang Z; Xu J; Chute DJ; Thorstad WL; Faraji F; Bishop JA; Mehrad M; Castro PD; Sikora AG; Thompson LDR; Chernock RD; Lang Kuhs KA; Wasman JK; Luo JR; Adelstein DJ; Koyfman SA; Lewis JS; Madabhushi A
    Cancer; 2022 Nov; 128(21):3831-3842. PubMed ID: 36066461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study.
    Kristensen MH; Sørensen MK; Tramm T; Alsner J; Sørensen BS; Maare C; Johansen J; Primdahl H; Bratland Å; Kristensen CA; Andersen M; Lilja-Fischer JK; Holm AIS; Samsøe E; Hansen CR; Zukauskaite R; Overgaard J; Eriksen JG
    Radiother Oncol; 2024 Apr; 193():110149. PubMed ID: 38341096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclo-oxygenase-2 Expression Is Associated With Lymph Node Metastasis in Oropharyngeal Squamous Cell Carcinoma Under the New TNM Classification.
    Sekimizu M; Ozawa H; Saito S; Ikari Y; Nakahara N; Nakamura S; Yoshihama K; Ito F; Watanabe Y; Imanishi Y; Kameyama K; Ogawa K
    Anticancer Res; 2019 Oct; 39(10):5623-5630. PubMed ID: 31570459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes.
    Barasch S; Mohindra P; Hennrick K; Hartig GK; Harari PM; Yang DT
    Am J Surg Pathol; 2016 Sep; 40(9):1261-9. PubMed ID: 27186851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma.
    Wuerdemann N; Gültekin SE; Pütz K; Wittekindt C; Huebbers CU; Sharma SJ; Eckel H; Schubotz AB; Gattenlöhner S; Büttner R; Speel EJ; Klussmann JP; Wagner S; Quaas A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma.
    Gorphe P; Chekkoury Idrissi Y; Tao Y; Moya-Plana A; Casiraghi O; Janot F; Blanchard P; Mirghani H; Temam S
    Head Neck; 2019 Apr; 41(4):1039-1045. PubMed ID: 30552841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
    Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
    Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Significance of p16 Cellular Localization in Oropharyngeal Squamous Cell Carcinoma.
    Lai S; Wenaas AE; Sandulache VC; Hartman C; Chiao E; Kramer J; Zevallos JP
    Ann Clin Lab Sci; 2016; 46(2):132-9. PubMed ID: 27098618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of BMI-1 and p16 as prognostic factors for head and neck carcinomas.
    Lundberg M; Renkonen S; Haglund C; Mattila PS; Leivo I; Hagström J; Mäkitie AA
    Acta Otolaryngol; 2016; 136(5):501-5. PubMed ID: 27052966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.
    Yildirim M; Müller von der Grün J; Winkelmann R; Fokas E; Rödel F; Ackermann H; Rödel C; Balermpas P
    Strahlenther Onkol; 2017 Apr; 193(4):305-314. PubMed ID: 28144684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Expression of CD44, a Cancer Stem Cell Marker, on the Treatment Outcomes of Intensity Modulated Radiation Therapy in Patients With Oropharyngeal Squamous Cell Carcinoma.
    Motegi A; Fujii S; Zenda S; Arahira S; Tahara M; Hayashi R; Akimoto T
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):461-8. PubMed ID: 26867875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging.
    Cheng NM; Yao J; Cai J; Ye X; Zhao S; Zhao K; Zhou W; Nogues I; Huo Y; Liao CT; Wang HM; Lin CY; Lee LY; Xiao J; Lu L; Zhang L; Yen TC
    Clin Cancer Res; 2021 Jul; 27(14):3948-3959. PubMed ID: 33947697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition.
    Gurin D; Slavik M; Hermanova M; Shatokhina T; Sana J; Kazda T; Selingerova I; Ahmad P; Smilek P; Horakova Z; Hendrych M; Slampa P; Slaby O
    J Oral Pathol Med; 2018 Oct; 47(9):864-872. PubMed ID: 30079604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of keratinization with 5-year disease-specific survival in oropharyngeal squamous cell carcinoma.
    Cooper T; Biron VL; Adam B; Klimowicz AC; Puttagunta L; Seikaly H
    JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):250-6. PubMed ID: 25554966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma.
    Lesinski GB; Nannapaneni S; Griffith CC; Patel M; Chen W; Chen Z; Ahmed R; Wieland A; Shin DM; Chen ZG; Saba NF
    Head Neck Pathol; 2019 Sep; 13(3):304-312. PubMed ID: 30191505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.